PAHO Director says COVID-19 vaccines for the Americas still recommended despite new variants

10 Feb 2021

“PAHO’s surveillance network is keeping a close watch on today’s variants of concern.”

Washington, D.C., February 10, 2021 (PAHO) Pan American Health Organization (PAHO) Director Carissa F. Etienne said the COVID-19 vaccines soon to be available from COVAX in the Americas are still recommended for the region, despite new variants of the SARS-CoV-2 virus that causes the disease.

Based on the evidence we have now on the variants of concern, we are confident that our growing portfolio of COVID-19 vaccines remains useful and will guide us through the end of this pandemic.”

PAHO Director Carissa F. Etienne

For more information go to


Webinar: Technical and regulatory aspects of prolonged use, reuse and reprocessing of respirators in periods of shortage

In 2 July 2020, the Pan American Health Organization (PAHO) organized a webinar on technical and regulatory aspects of prolonged use, reuse and reprocessing of respirators in periods of shortage.

Such webinar aimed to present issues related to the extended use, reuse, and reprocessing of N95 and equivalent respirators by health services during shortages of this personal protective equipment (PPE), to health facility managers, health authorities, and others involved in decision-making on the use and prioritization of PPE.

This session was based on a PAHO document that presents considerations for the prolonged use, reuse, and reprocessing of N95 respirators and equivalents by health services during periods of shortage of PPE. This document summarizes the available evidence on existing reprocessing methods for N95 respirators and equivalents. The recommendations are preliminary and are subject to review as new evidence becomes available. This document is available at

The webinar is available in English at the Campus Virtual for Public Health: